SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, IN POSTMENOPAUSAL WOMEN: AN ASCENDING SINGLE AND MULTIPLE DOSE PHASE I STUDY

被引：0
|
作者：
Nagase, S. [1 ]
Hashimoto, Y. [2 ]
Ohyama, M. [3 ]
Kuwayama, T. [1 ]
Deacon, S. [1 ]
机构：
[1] Ono Pharma UK Ltd, London, England
[2] Ono Pharmaceut Co Ltd, Tsukuba, Ibaraki, Japan
[3] Ono Pharmaceut Co Ltd, Osaka, Japan
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN: A MULTIPLE DOSE PHASE I STUDY
    Nagase, S.
    Ohyama, M.
    Small, M.
    Kuwayama, T.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 338 - 338
  • [2] Safety and Efficacy of the Cathepsin K Inhibitor ONO-5334 in Postmenopausal Osteoporosis: The OCEAN Study
    Eastell, Richard
    Nagase, Shinichi
    Ohyama, Michiyo
    Small, Maria
    Sawyer, James
    Boonen, Steven
    Spector, Tim
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (06) : 1303 - 1312
  • [3] Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO-5334, in an Ascending Multiple-Dose, Phase 1 Study
    Nagase, Shinichi
    Ohyama, Michiyo
    Hashimoto, Yoshitaka
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03): : 306 - 318
  • [4] Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women
    Nagase, Shinichi
    Hashimoto, Yoshitaka
    Small, Maria
    Ohyama, Michiyo
    Kuwayama, Tomohiro
    Deacon, Steve
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (06) : 959 - 970
  • [5] The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study
    Engelke, Klaus
    Nagase, Shinichi
    Fuerst, Thomas
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Stephen
    Eastell, Richard
    Genant, Harry K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (03) : 629 - 638
  • [6] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    Eastell, R.
    Dijk, D. -J.
    Small, M.
    Greenwood, A.
    Sharpe, J.
    Yamada, H.
    Yuba, M.
    Tanimoto, M.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 309 - 318
  • [7] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    R. Eastell
    D.-J. Dijk
    M. Small
    A. Greenwood
    J. Sharpe
    H. Yamada
    M. Yuba
    M. Tanimoto
    S. Deacon
    Osteoporosis International, 2016, 27 : 309 - 318
  • [8] Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2011, 49 (06) : 1351 - 1356
  • [9] EFFECT OF ONO-5334, A NOVEL CATHEPSIN K INHIBITOR, ON BONE TURNOVER MARKERS IN CYNOMOLGUS MONKEYS
    Mori, H.
    Yamada, H.
    Kunishige, A.
    Nishikawa, S.
    Hashimoto, Y.
    Tanaka, M.
    Shiroya, T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 336 - 336
  • [10] Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
    Makoto Tanaka
    Yoshitaka Hashimoto
    Chihiro Hasegawa
    Steve Deacon
    Richard Eastell
    BMC Musculoskeletal Disorders, 18
12345